Evolus Stock (NASDAQ:EOLS)
Previous Close
$6.95
52W Range
$5.71 - $17.12
50D Avg
$6.62
200D Avg
$9.51
Market Cap
$455.68M
Avg Vol (3M)
$1.24M
Beta
0.88
Div Yield
-
EOLS Company Profile
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.